Taken together, these data demonstrate that knockdown of Mlkl with AAV-shRNA in hepatocytes markedly ameliorates CCl4-induced hepatocyte damage, liver inflammation, and hepatic fibrosis. This evidence concerns the gene MLKL and Hepatic fibrosis.